{"count": 2, "results": [{"_id": "24059335", "pmid": 24059335, "title": "Hybrid molecules synergistically acting against protein aggregation diseases.", "journal": "Curr Top Med Chem", "authors": ["Korth C", "Klingenstein R", "Müller-Schiffmann A"], "date": "2013-01-01T00:00:00Z", "doi": "10.2174/15680266113136660175", "meta_date_publication": "2013", "meta_volume": "13", "meta_issue": "19", "meta_pages": "2484-90", "score": 50046.633, "text_hl": "An emerging common feature of the age-associated @DISEASE_Neurodegenerative_Diseases @DISEASE_MESH:D019636 @@@neurodegenerative disorders@@@ like @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@ (@DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@AD@@@) and @<m>DISEASE_Creutzfeldt_Jakob_Syndrome</m> @DISEASE_MESH:D007562 @@@Creutzfeldt-Jakob disease@@@ (@<m>DISEASE_Creutzfeldt_Jakob_Syndrome</m> @DISEASE_MESH:D007562 @@@CJD@@@) is the ability of many disease-associated protein aggregates to induce conversion of a normal counterpart conformer leading to an acceleration of disease progression. ", "citations": {"NLM": "Korth C, Klingenstein R, Müller-Schiffmann A. Hybrid molecules synergistically acting against protein aggregation diseases. Curr Top Med Chem. 2013;13(19):2484-90. PMID: 24059335", "BibTeX": "@article{24059335, title={Hybrid molecules synergistically acting against protein aggregation diseases.}, author={Korth C and Klingenstein R and Müller-Schiffmann A}, journal={Curr Top Med Chem}, volume={13}, number={19}, pages={2484-90}}"}}, {"_id": "16749906", "pmid": 16749906, "title": "Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments.", "journal": "J Neurochem", "authors": ["Klingenstein R", "Löber S", "Kujala P", "Godsave S", "Leliveld SR", "Gmeiner P", "Peters PJ", "Korth C"], "date": "2006-08-01T00:00:00Z", "doi": "10.1111/j.1471-4159.2006.03889.x", "meta_date_publication": "2006 Aug", "meta_volume": "98", "meta_issue": "3", "meta_pages": "748-59", "score": 50036.707, "text_hl": "Our data suggest that a cocktail of drugs targeting the @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ metabolism that controls @GENE_PRNP @GENE_5621 @@@PrP@@@ conversion may be the most efficient in treating @<m>DISEASE_Creutzfeldt_Jakob_Syndrome</m> @DISEASE_MESH:D007562 @@@Creutzfeldt-Jakob disease@@@.", "citations": {"NLM": "Klingenstein R, Löber S, Kujala P, Godsave S, Leliveld SR, Gmeiner P, Peters PJ, Korth C. Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments. J Neurochem. 2006 Aug;98(3):748-59. PMID: 16749906", "BibTeX": "@article{16749906, title={Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments.}, author={Klingenstein R and Löber S and Kujala P and Godsave S and Leliveld SR and Gmeiner P and Peters PJ and Korth C}, journal={J Neurochem}, volume={98}, number={3}, pages={748-59}}"}}]}